Yahoo! Finance: Top Stories

Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market

Mar 29, 2025 - 12:31
 0
Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market
Read More

Tags:

Previous Article

Corvex’s Meister joins the board at Illumina. Here’s how he can create value for...

Next Article

Lululemon exceeds $10bn in annual revenue with strong Q4 FY24

Related Posts

Trump’s Car Tariffs Are Worse Than the Worst-Case Scenario. GM Stock Tumbles.

Trump’s Car Tariffs Are Worse Than the Worst-Case Scena...

Mar 27, 2025  0

Why CareTrust, Genuine Parts, And Hess Midstream Are Winners For Passive Income

Why CareTrust, Genuine Parts, And Hess Midstream Are Wi...

Mar 30, 2025  0

These Stocks Are Moving the Most Today: Intel, MicroStrategy, Tesla, Super Micro, BAE Systems, Southwest, and More

These Stocks Are Moving the Most Today: Intel, MicroStr...

Mar 3, 2025  0